Introducing Koala Prospector! Bringing Waterfall Enrichment to Reps

Learn More!
aTyr Pharma

aTyr Pharma

aTyr is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways. aTyr's research and development efforts are concentrated on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. aTyr has built a global intellectual property estate directed to a potential pipeline of protein compositions derived from 20 tRNA synthetase genes and their extracellular targets. aTyr's primary focus is efzofitimod, a clinical-stage product candidate which binds to the neuropilin-2 receptor and is designed to downregulate immune engagement in inflammatory lung diseases.

Last updated on

About aTyr Pharma

Founded

2005

Estimated Revenue

$1M-$10M

Employees

51-250

Funding / Mkt. Cap

$403M

Category

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Location

City

San Diego

State

California

Country

United States

Tech Stack (88)

search

Programming Languages And Frameworks

Business Intelligence And Analytics

Communications

Productivity And Operations

Customer Management

IT Security

Computer Networks

IT Management

Audio / Video Media

Content Management System

Web Servers

Verified CDN